Hemophilia: Understanding a Bleeding Disorder

Hemophilia is an inherited bleeding disorder caused by deficiency or dysfunction of clotting factors, leading to impaired blood coagulation.

Main Types

  • Hemophilia A: Factor VIII deficiency (≈80% of cases)
  • Hemophilia B: Factor IX deficiency (≈20% of cases)

Both are X-linked recessive disorders, predominantly affecting males. Females are usually carriers but can be symptomatic due to lyonization.

Clinical Features

  • Prolonged bleeding after injury, surgery, or dental procedures
  • Spontaneous bleeding into joints (hemarthrosis), muscles, and soft tissues
  • Severity correlates with factor level: severe (<1%), moderate (1–5%), mild (5–40%)

Diagnosis and Management

  • Diagnosis: Prolonged aPTT, normal PT/INR, low specific factor assay
  • Treatment: Recombinant or plasma-derived factor concentrates (on-demand or prophylactic)
  • Complications: Inhibitor development (antibodies to factor), joint arthropathy, viral transmission (historical)

With modern prophylactic factor replacement and comprehensive care at hemophilia treatment centers, individuals with hemophilia can achieve near-normal life expectancy and quality of life.

Blood Disorders - Related Articles